Treace Medical Concepts, Inc.
corporate_fare Company Profile
Treace Medical Concepts, Inc. (NASDAQ:TMCI) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for TMCI at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Treace Medical Reports Q4 Revenue Decline, Withholds 2026 Guidance Amid Headwinds
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$212.69M
Net Income
-$59M
Diluted EPS
-$0.93
Op. Cash Flow
-$15.97M
Free Cash Flow
-$29.49M
Gross Profit
$169.75M
Operating Income
-$54.15M
Cash & Equivalents
$10.71M
Total Debt
$57.33M
Debt / Equity
0.66×
Net Margin
-27.7%
Shares Outstanding
63.27M sh
Source: 10-K · filed 2026-02-27 · accession 0001193125-26-079167
show_chartPrice Chart
Loading chart...
feed TMCI - Filings & News (Page 2)
TMCI
Jan 13, 2026, 8:54 AM EST
Price at Filing:
$2.71
Real-time Price:
$4.31
Change:
+$1.60 (+59%)
Market Cap:
$282.562M